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Abstract
Background: H9N2 influenza viruses circulate globally and are considered to have pandemic potential. The
hyper-inflammatory response elicited by these viruses is thought to contribute to disease severity. Calcitriol
plays an important role in modulating the immune response to viral infections. However, its unknown whether calcitriol
can attenuate the inflammatory response elicited by H9N2 influenza virus infection.
Methods: Human lung A549 epithelial cells were treated with calcitriol (100 nM) and then infected with an H9N2
influenza virus, or infected and then treated with calcitriol (30 nM). Culture supernatants were collected every
24 h post infection and the viral growth kinetics and inflammatory response were evaluated. Calcitriol (5 mg/kg) was
administered daily by intraperitoneal injection to BABL/c mice for 15 days following H9N2 influenza virus infection.
Mice were monitored for clinical signs of disease, lung pathology and inflammatory responses.
Results: Calcitriol treatment prior to and post infection with H9N2 influenza significantly decreased expression of the
influenza M gene, IL-6, and IFN-β in A549 cells, but did not affect virus replication. In vivo, we found that calcitriol
treatment significantly downregulated pulmonary inflammation in mice 2 days post-infection, but increased the
inflammatory response 4 to 6 days post-infection. In contrast, the antiviral cytokine IFN-β was significantly higher in
calcitriol-treated mice than in the untreated infected mice at 2 days post-infection, but lower than in untreated
infected mice on days 4 and 8 post-infection. The elevated levels of pro-inflammatory cytokines and the decreased
levels of antiviral cytokine are consistent with the period of maximum body weight loss and the lung damage in
calcitriol-treated mice.
Conclusions: These results suggest that calcitriol treatment might have a negative impact on the innate immune
response elicited by H9N2 infection in mice, especially at the later stage of influenza virus infection. This study
will provide some novel insights into the use of calcitriol to modulate the inflammatory response elicited by
influenza virus infection in humans.
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Background
Calcitriol, also known as 1, 25-dihydroxy-vitamin D3 (1,
25-(OH)2D3), is the biologically active form of vitamin
D [1, 2]. The association between vitamin D and calcium
homeostasis and bone metabolism is well established,
but recently vitamin D has also been shown to regulate
the immune system [1, 3], suggesting that understanding
the pleotropic effects of vitamin D is important. The
biological effects of 1,25-(OH)2D3 are mediated by the
vitamin D receptor (VDR), which is expressed on many
immune cells. Vitamin D affects cytokine production
during the innate immune response, which also affects
the subsequent adaptive immune responses [4].
Vitamin D deficiency is now recognized as a pandemic
[5] and has been associated with an increased risk of re-
spiratory infections. Vitamin D supplements reduce the
risk of acute respiratory infection [6, 7]. Many observa-
tional studies have shown that vitamin D status is in-
versely associated with the prevalence of common colds
[8–10]. Calcitriol treatment in human pulmonary epithe-
lial cells (A549) before or after infection with an H1N1
influenza virus did not affect A549 cell viability, viral
clearance or the anti-viral state following infection.
However, expression of pro-inflammatory cytokines and
chemokines was reduced at the genetic level [11], which
may help alleviate the severity of the disease. In contrast,
treatment with 1,25(OH)2D3 did not affect the expression
pattern of human pro-inflammatory and anti-inflammatory
responses elicited by viral pattern recognition receptor li-
gands at either physiologic or pharmacologic concentra-
tions [12]. In addition, there are reports that vitamin D
supplements do not increase the humoral immune to the
influenza vaccine [13, 14]. Therefore, it remains unclear
what effects vitamin D supplements have on the immune
response to viral infection.
H9N2 subtype influenza viruses are the principal influ-
enza strain reported in poultry and has circulated globally
since their first detection in turkeys in 1966 [15]. They have
also been detected in multiple other species [16]. In mam-
malian hosts, the H9N2 influenza viruses have been shown
to provide internal genes to other influenza subtypes to cre-
ate novel genotypes, such as H7N9 and H5N1 [17, 18].
Therefore, the H9N2 subtype influenza viruses play a sig-
nificant role in the evolution of new influenza strains and
are considered to have pandemic potential by the World
Health Organization [19, 20]. H9N2 viruses were founded
to elicit a markedly higher expression of inflammatory che-
mokines and cytokines than seasonal influenza viruses,
which might contribute to the more severe disease caused
by H9N2 viruses [20, 21]. Thus, immunomodulatory
treatment strategies for influenza that suppress a hyper-
inflammatory response may benefit influenza patients.
In this study, we hypothesized that calcitriol would
reduce the inflammatory response elicited by H9N2
infection. To test this hypothesis, we treated human lung
A549 epithelial cells and BABL/c with calcitriol and then
characterized the inflammatory response to infection with
an H9N2 influenza strain.
Methods
Virus
The H9N2 influenza virus used in this study was isolated
from a wild duck in 2011 by our laboratory, and is similar
to the 2009 human H9N2 isolates (HK/35820/2009 and
HK/33982/2009). The strain is capable of inducing acute
lung injury in BALB/c mice [22]. The complete genome
sequences (JQ901621, JQ901632, JQ901643, JQ901654,
JQ901665, JQ901676, JQ901687, and JQ901698) of the
virus can be obtained from GenBank (National Center for
Biotechnology Information, Bethesda, MD). To generate a
stock, the virus was inoculated into the allantoic cavity of
10-day-old specific pathogen free (SPF) chicken embryos
(Beijing Laboratory Animal Research Center, China) and
incubated at 37 °C for 72 h. The allantoic fluid was then
collected and stored at −80 °C until further use. The 50%
tissue culture infection dose (TCID50) was determined in
A549 cells as in our previous study [22].
Reagents and cell lines
Calcitriol (Sigma-Aldrich, St. Louis, MO) was dissolved
in ethanol to prepare a stock solution (1 mg/mL) and
stored at −80 °C until further use. The stock solution
was diluted to the desired concentration for experiments
using culture medium or 0.9% sterile saline.
The human alveolar epithelial cell line A549 was pur-
chased from the Cell Bank of Chinese Academy of
Sciences, Shanghai, China. The cells were cultured in
Dulbecco's Modified Eagle Medium (DMEM) (HyClone)
containing 10% Fetal Bovine Serum (FBS) (Gibco) and
1% penicillin-streptomycin (Gibco). The A549 cells were
grown at 37 °C in a 5% CO2 atmosphere.
The effect of calcitriol on A549 cells
A549 cells were grown in T-25 tissue culture flasks
(Corning) to approximately 75% confluence prior to use
in experiments. The methods of measuring the effects of
calcitriol pre- or post-treatment on the A549 cells were
based on previous studies [11]. Briefly, calcitriol pre-
treated A549 cells were incubated with calcitriol (100nM)
for 16 h and then infected with H9N2 (1 mL volume,
1:200 dilution from stock, TCID50 = 106.7) for 1 h at
37 °C in a 5% CO2 atmosphere. After 1 h, the virus
containing medium was removed and the cells were
washed twice by PBS, then fresh DMEM containing 2 ×
pen-strep but no FBS was added and the cells were incu-
bated at 37 °C in a 5% CO2 atmosphere for an additional
72 h. For cells that were treated with calcitriol after infec-
tion, virus infection was performed as described above
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and after the virus containing medium was removed, the
infected cells were incubated with calcitriol (30nM) 72 h.
The cell culture supernatants were harvested 24, 48, and
72 h post infection and the cell debris was removed by
centrifugation. The TCID50 of the virus in the super-
natant was determined in A549 cells to quantify the
growth kinetics of the influenza virus in the absence
and presence of calcitriol. Real-time PCR was performed
to detect the expression levels of the influenza M gene,
IL-6, and IFN-β.
Mice
Specific-pathogen-free BALB/c female mice (aged 6–8
weeks) were purchased from Nanjing Pengsheng Bio-
logical Technology Co., Ltd. (China). Animals were main-
tained according to the National Institutes of Health
(NIH) standards established in the Guidelines for the Care
and Use of Experimental Animals, and all of the experi-
mental protocols were reviewed and approved by the
Animal Investigation Committee of East China Normal
University. During the experiments, mice were provided
ad libitum access to food and water in an environmentally
controlled atmosphere with a 12-h light/dark cycle.
Assessing the tolerability of calcitriol treatment in mice
To investigate whether there were any side effects of cal-
citriol treatment in mice, animals were divided randomly
into a control or calcitriol treated group (n = 6 mice/
group). The calcitriol-treated mice received intraperito-
neal injections of calcitriol (5 mg/kg body weight) daily
for 2 weeks [23, 24]. The control group received an intra-
peritoneal injection of an equivalent volume of sterile sa-
line daily. Clinical signs (including body weight change,
inactivity and mortality) and behavior were monitored
daily for 2 weeks.
Assessing the effects of calcitriol treatment on the course
of influenza infection in mice
To study the effects of calcitriol supplementation on
H9N2 virus-induced lung injury, BALB/c mice were ran-
domly divided into an infected control group, calcitriol-
treated infected group, and uninfected control group (n
= 30 mice/group). Animals were lightly anaesthetized
with diethyl ether, and mice in the infected control
group and the calcitriol-treated infected group were in-
oculated intranasally with 100 μL of the H9N2 influenza
virus A/mallard/Jiangxi/39/2011 allantoic fluid (1 × 106
50% egg infection dose), while the uninfected control
group mice were inoculated intranasally (100 μL) with
an equivalent dilution of noninfectious allantoic fluid.
Mice in all groups were administered calcitriol or saline
starting the next day, and their general behavior and
clinical signs were monitored daily. Five mice from each
group were euthanized on 2, 4, 6, 8 and 15 days post-
infection. The whole l ungs were harvested and stored at
−80 °C for histopathology observation, inflammatory
cytokine and viral gene analysis. Mice were euthanized
using CO2 when their weight loss was ≥25% of their
initial body weight. All efforts were made to minimize
animal suffering.
Histopathology measurement
At the time points indicated, half lung lobes from each
mouse were fixed in buffered 10% formalin for 7 days,
then embedded in paraffin, sectioned (5 μm slices), and
stained with hematoxylin-eosin. All samples were ran-
domly numbered and examined using light microscopy
by a blinded veterinary pathologist [25]. The total lung
histopathological scores for each section were calculated
by adding the separate scores. The change in the histo-
pathological scores over time was expressed as the mean
± SEM at each time point.
Real-time quantitative PCR analysis
The expression levels of IL-2, IL-4, IL-6, TNF-α, IFN-
β,VDR and the H9N2 M gene were assessed by relative
quantitative real-time PCR (qPCR) performed using the
Applied Biosystems 7300 system (Life Technologies,
Carlsbad, CA) [26]. Total RNA was extracted from A549
cells and lung samples using the RNeasy Mini Kit (QIA-
GEN) per the manufacturer’s instructions. Random primers
(Promega, Madison, WI) and Superscript III (Life Tech-
nologies) were used to synthesize first-strand complemen-
tary DNA from equivalent amounts of RNA. The qPCR
primers were designed using Primer Express software (Life
Technologies). The housekeeping gene β-actin was used as
an internal control. The amplification efficiencies of the tar-
get genes and the β-actin gene were determined by serially
diluting the cDNA and performing qPCR [27]. The amplifi-
cation efficiencies were close to 100% (data not shown).
qPCR was performed using the SYBR Green PCR master
mix (Takara, Dalian, China) under the following reaction
conditions: 95 °C for 30 s and 40 cycles of 95 °C for 5 s,
60 °C for 31 s, and a dissociation step. Each sample was
amplified in quadruplicate. All data were analyzed using
he Sequence Detector Systems software (Life Technolo-
gies). Relative quantification (RQ) was carried out using
the 2-ΔΔCt method in which the average threshold
cycle (ΔCt) values of the control group were used for
calibration [28]. The sequences of primers used in this
study are available upon request.
Statistical analysis
All data were analyzed using the Statistical Package for
Social Science version 17.0 (SPSS, Inc., Chicago, IL). Re-
sults are expressed as the mean ± SEM. The one-way
analysis of variance (ANOVA) followed by a post-hoc
Tukey test or unpaired two-tailed t-test was used to
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evaluate the statistical significance of differences be-
tween two groups. P-values less than 0.05 were consid-
ered statistically significant.
Results
The effects of calcitriol treatment in A549 cells
We hypothesized that the immunomodulatory effects
of calcitriol would attenuate the effects of H9N2 influ-
enza in A549 cells. To establish that any observed at-
tenuation was not the result of deficient viral growth,
we first tested whether calcitriol treatment affected the
growth kinetics of H9N2 influenza in A549 cells. The
culture supernatants from infected cells were harvested
every 24 h and the viral load was determined by
TCID50 assay. The growth kinetics of H9N2 influenza
in cells pre-treated with calcitriol or treated with calci-
triol post infection were similar to that of infected cells
in the absence of calcitriol (Fig. 1a). In all cases, the
viral titer peaked at 48 h post infection and then
plateaued. These results indicate that the replication
competence of H9N2 influenza is not influenced by the
calcitriol treatment.
Based on the viral growth kinetics, we selected the 48h
post infection time point to assess the relative mRNA
expression levels of the viral M gene, IL-6 and IFN-β by
real-time PCR. Significant increases in the expression
levels of the M gene (Fig. 1b), IL-6 (Fig. 1c) and IFN-β
(Fig. 1d) were observed in A549 cells infected with
H9N2 influenza compared with uninfected control cells,
indicating that hyperinflammatory responses were elic-
ited by H9N2 influenza virus infection. Treatment with
calcitriol pre-infection and post-infection significantly
reduced the expression of the M gene (Fig. 1b). In the
uninfected cells, regardless of calcitriol treatment, no M
gene expression was detected. Similar changes were ob-
served with regard to expression levels of IL-6 and IFN-
β in H9N2 infected A549 cells treated with calcitriol
pre- or post- infection (Fig. 1c and d). Taken together,
a b
c d
Fig. 1 The effects of calcitriol on A549 cells. a Effect of calcitriol treatment on virus growth kinetic in A549 cells. Cell culture supernatants were
harvested every 24 h from infected cells and the viral load was titrated using the TCID50 assay. Real-time PCR was used to measure the effect of
calcitriol treatment on the mRNA expression levels of the viral M gene (b), IL-6 (c), and IFN-β (d) in A549 cells. β-actin was used as an internal control.
The data are expressed as mean ± SEM of triplicate samples
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these results suggested that calcitriol might reduce the im-
mune response to H9N2 influenza infection in A549 cells.
Assessing the effects of calcitriol treatment in mice
Given that in vitro calcitriol appeared to dampen the in-
flammatory response to H9N2 infection in A549 cells,
we then hypothesized that calcitriol treatment might
attenuate the clinical symptoms of H9N2 infection in
mice. To determine whether calcitriol administration
was well tolerated in mice the clinical signs and body
weight of uninfected mice treated with calcitriol were
monitored daily. No changes were observed in either the
body weight (Fig. 2) or clinical signs (data not shown)
when comparing calcitriol-treated and untreated mice.
Calcitriol administration was also not associated with
morbidity. Together these results indicated that the
5 mg/kg body weight calcitriol dose chosen for this
study was well tolerated.
We then compared the effects of H9N2 infection in
mice treated with calcitriol to untreated mice. We found
that body weight decreased in infected mice on days 1–2
after H9N2 virus infection irrespective of calcitriol treat-
ment. Furthermore, on days 3–7 post-infection, infected
mice also exhibited severe clinical signs, including
marked inactivity, emaciation, ruffled fur, lack of appe-
tite, and signs of labored breathing and respiratory dis-
tress (data not shown). The body weight loss was greater
in the calcitriol-treated infected group than in the
infected control group, but the difference was not sig-
nificant (Fig. 2). The uninfected mice showed no clinical
signs of infection. These findings indicated that daily
treatment with calcitriol did not alleviate the clinic
symptoms of H9N2 virus in infected mice.
Lung histopathology and M gene expression in mice
treated with calcitriol
To understand whether calcitriol treatment impacted
lung pathology associated with H9N2 infection, lung
samples were collected on days 2, 4, 6, and 8 post-
infection and examined by light microscopy. The histo-
pathology scores for mice infected with H9N2 influenza
are provided in Table 1. Representative histology images
are shown in Fig. 3. Regardless of calcitriol treatment,
infected mice exhibited similar pathological patterns,
including collapse of the alveolar space, infiltration of
inflammatory cells, interstitial and alveolar edema, and
hemorrhage. The change in the histopathology score for
calcitriol-treated infected mice was less than the un-
treated infected mice 2 days post-infection, but greater
on days 4 and 6 post-infection (Table 1 and Fig. 3). At
later time points the infected mice had significant mar-
gination and infiltratory cells with profuse hemorrhage
and edema. The results suggested that rather than at-
tenuating H9N2 pathology, calcitriol treatment might
exacerbate lung damage during the later stages of influ-
enza virus infection.
The expression of the H9N2 M gene was measured by
real-time quantitative PCR (Fig. 4) mRNA for the M
gene was detectable from 2 to 8 days post-infection in
all of the infected mice. However, expression levels were
slightly higher in the calcitriol treated mice compared to
the untreated infected mice from 2 to 6 days post-
infection. Notably, expression levels in the calcitriol
treated mice were twice that in the untreated infected
mice 6 days post-infection. There were no differences be-
tween the two groups by 8 days post-infection. Consistent
with the histology findings, these results suggested that
calcitriol treatment might increase the expression levels of
influenza M gene in the lungs.
Expression of pro-inflammatory and antiviral cytokines in
the lungs of calcitriol treated mice
To investigate the effects of calcitriol treatment on the
expression of pro-inflammatory cytokines (IL-2, IL-4, IL-
6 and TNF-α) and antiviral cytokines (IFN-β) following
H9N2 influenza virus infection, lung samples were har-
vested at the times indicated and the relative mRNA ex-
pression levels were calculated using the 2-ΔΔCt method.
Compared to uninfected mice, the expression levels of
IL-2, IL-4, IL-6 and TNF-α in H9N2 influenza virus
infected control mice were similar, which was elevated
significantly on day 2 post-infection and reached a peak on
Fig. 2 Body weight change in mice. White circles indicate mice
inoculated with noninfectious allantoic fluid and treated with sterile
saline from days 1 to 15 post-infection; Black circles indicate mice
inoculated with noninfectious allantoic fluid and injected with calcitriol
(5 mg/kg) intraperitoneally; White triangles indicate mice infected with
the H9N2 virus and treated with calcitriol (5 mg/kg) from days 1 to 15
post-infection; Black triangles indicate mice infected with the H9N2
virus and treated with sterile saline from days 1 to 15 post-infection.
Data presented are the mean ± SEM for 6 mice per group
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this day and then began to decline on day 8 (Fig. 5a–d).
Interestingly we found that the levels of TNF-α, IL-2 and
IL-4 returned to baseline or were decreased compared to
the uninfected control group by 4 to 6 days post-infection.
The expression levels of IL-2, IL-4, IL-6 and TNF-α in
calcitriol-treated infected mice were significantly lower
than the untreated infected mice on 2 days post-
infection (p <0.01). However, the expression levels were
higher than the untreated infected mice on 4 and 6 days
post-infection. In particular, the levels of IL-6 were up-
regulated up to 5.6 fold in calcitriol-treated infected
mice at 4 days post-infection.
In the absence of calcitriol treatment, the expression
levels of IFN-β in infected mice increased at 2 days post-
infection, peaked at 4 days post-infection, and then
began to decline. In contrast, to the proinflammatory
cytokines, IFN-β expression levels were significantly
higher in the calcitriol treated infected mice than in
the untreated infected mice on days 2 post-infection,
but significantly lower at 4 and 8 days post-infection
(p <0.01; Fig. 5e).
Calcitriol treatment upregulated expression of VDR in
the lung
The biological effects of calcitriol are mediated by the
vitamin D receptor (VDR). As shown in Fig. 6, the
expression of VDR mRNA was greater in mice treated
with calcitriol than in untreated mice, the greatest
difference being approximately 2.5-fold on 6 days
post-infection.
Discussion
H9N2 viruses are known to elicit a hyperinflammatory
reponse that includes cytokines such as IL-6 and TNF-a,
that may play an important role in contributing to
pathogenicity [20, 21, 29]. In A549 cells, we found that
IL-6 and IFN-β were significantly upregulated response
to H9N2 influenza virus infection. This is consistent
with findings from avian H9N2 infection in A549 cells
and TBE cells (tracheobronchial epithelial) eliciting a
pro-inflammatory cytokine response including produc-
tion of IL-6, IL-1β, and IFN-β [30, 31]. In vivo, we found
that that the expression levels of IL-2, IL-4, IL-6 and
TNF-a in the lungs of H9N2 infected mice peaked on
2 days post-infection and then declined on days 4 and 6
post-infection. Interestingly, the expression levels of
IFN-β did not peak until 4 days post-infection and then
declined. The increased cytokine levels were associated
with the period of most dramatic body weight loss and
the expression of the influenza M gene in the lungs.
Therefore, the cytokine dysregulation in response to
H9N2 influenza virus infection might contribute to the
increased severity of the disease, especially in the early
stages of the infection.
Vitamin D plays important roles in modulating the in-
nate immune response to viral infection and can suppress
the inflammatory response [32, 33]. We hypothesized that
calcitriol would attenuate the inflammatory response
induced by H9N2 influenza virus infection. In A549 cells
we found that treatment with calcitriol prior to and
post infection with H9N2 influenza significantly
Table 1 Histological examination of the lung tissue
Parameter Days post-infection
2 4 6 8
Hemorrhage
Infectiona 0.87 ± 0.35 2.27 ± 0.45 2.12 ± 0.75 0.42 ± 0.5
Infection + Calcitriolb 0.78 ± 0.44 2.53 ± 0.51* 3.05 ± 0.58** 0.96 ± 0.81**
Alveolar and interstitial edema
Infectiona 1 ± 0.53 1.82 ± 0.59 2.08 ± 0.86 0.96 ± 0.53
Infection + Calcitriolb 1.11 ± 0.78 3.03 ± 0.64** 2.45 ± 0.6* 0.93 ± 0.38
Margination and infiltration
Infectiona 1.62 ± 0.52 2.77 ± 0.43 2.59 ± 0.67 1.73 ± 0.45
Infection + Calcitriolb 1.44 ± 0.53 3.25 ± 0.64* 3.5 ± 0.51** 1.52 ± 0.51
Alveolar collapse
Infectiona 1.75 ± 0.46 2.68 ± 0.48 2.96 ± 0.76 1.69 ± 0.47
Infection + Calcitriolb 1.22 ± 0.44 3.25 ± 0.52* 3.18 ± 0.5 1.37 ± 0.49
Total lung injury score
Infectiona 5.25 ± 1.16 9.54 ± 1.22 9.75 ± 2.38 4.81 ± 1.52
Infection + Calcitriolb 4.55 ± 1.67 12.1 ± 1.54** 12.2 ± 1.18** 4.78 ± 1.25
Data are presented as the mean ± SEM, unless otherwise stated. a: Mice infected with the H9N2 virus and treated with sterile saline from days 1 to 15 post-infection;
b: Mice infected with the H9N2 virus and treated with calcitriol (5 mg/kg body weight) from days 1 to 15 post-infection; *P <0.05; **P <0.01
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decreased the mRNA expression levels of IL-6, IFN-β
and the viral M gene compared to infected cells not
treated with calcitriol. Treatment did not affect H9N2
replication in A549 cells. This suggested that calcitriol
treatment might downregulate the immune response to
the H9N2 avian influenza virus infection in vitro assays.
To determine the effects of calcitriol treatment on the
clinical course of H9N2 infection we used a mouse model
and characterized the inflammatory response to infection.
Calcitriol treatment did not attenuate the clinic symptoms
of H9N2 infected mice, and in fact body weight loss was
slight greater in the calcitriol-treated infected group than
in the untreated infected group. While calcitriol treatment
slightly attenuated the severity of the lung lesions in in-
fected mice during early infection, it significantly aggra-
vated lung damage in the later stage of influenza virus
infection. Calcitriol treatment also increased the mRNA
levels of the influenza M protein from 2 to 6 days post-
infection. The increase in influenza M gene expression in
calcitriol-treated mice was consistent with the increased
disease severity. The M protein is not only directly related
to virus replication, it also can lead to the activation of
inflammasomes [34], and therefore we quantified the
inflammatory response.
We characterized the inflammatory response by meas-
uring the mRNA expression levels of pro-inflammatory
Fig. 3 Changes in lung histopathology of calcitriol treated mice. Lung samples were harvested from calicitriol (5 mg/kg) treated H9N2 infected
mice on days 2 (A), 4 (B), 6 (C), and 8 (D) post infection. Lung tissues were harvested from untreated H9N2 infected mice on days 2 (E), 4 (F), 6
(G), and 8 (H) post-infection. Original magnification 100 ×
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and antiviral cytokines. Calcitriol treatment reduced the
expression of the pro-inflammatory cytokine IL-6 at the
earliest stages of infection, but increased its expression
in the later stages of infection. In contrast, the antiviral
cytokine IFN-β was significantly higher in calcitriol-
treated mice than in the untreated infected mice at
2 days post-infection, but lower in the calcitriol treated
mice on days 4 and 8 post-infection. The increase in
pro-inflammatory IL-6 and the decrease in antiviral IFN-
β are consistent with the changes the lung lesions in
calcitriol-treated mice. Taken together these results sug-
gest that calcitriol treatment might hamper the innate
immune response to H9N2 influenza virus infection in
mice, especially at the later stage of influenza virus infec-
tion. The changed we observed in the levels of IL-2 and
IL-4 were similar to previous reports demonstrating that
IL-2 and IL-4 were downregulated in chicken macro-
phages infected with an H9N2 avian influenza virus, This
study suggested that cytokine downregulation might
have an overall negative impact on the development of
adaptive immunity in chickens [30]. While the expression
levels of IL-2 and IL-4 in calcitriol treated mice were a
slightly higher following infection than in untreated mice
at days 4 to 6 post-infection, there were no marked differ-
ences between the three groups. Therefore, it is still unclear
whether IL-2 and IL-4 play a negative role in the develop-
ment of the adaptive immune response in this model.
Vitamin D binds to VDR, a steroid/thyroid hormone
nuclear receptor, which has been identified on many im-
mune cells, suggesting vitamin D may have a regulatory
role in the immune system. To investigate whether the
effects of calcitriol in mice may have been due to in-
creased expression of VDR in the lungs we determined
the level of VDR expression by PCR. Expression of VDR
in the lungs of the calcitriol-treated infected mice was
higher than in the untreated infected mice at the times
indicated. Upregulation of VDR in response to vitamin
D has also been observed in vivo [35]. Calcitriol treat-
ment resulting in elevated VDR levels can be explained
by a similar rise observed in the proinflammatory cyto-
kines that triggers the hyper-responsiveness induced in-
fluenza virus infection. Therefore, VDR elevation might
be involved in the inflammatory processes in vivo.
In summary, calcitriol has been shown to have a posi-
tive effect on the inflammatory response in vitro. How-
ever, daily treatment with calcitriol following H9N2
influenza virus infection did not attenuate the clinical
severity of the disease, and in fact slightly increased the
inflammatory response and the severity of lung injury
during the later stage of infection. The reason for the
Fig. 4 Expression of the H9N2 M gene in the lungs of infected mice after treatment with calcitriol. Mice were inoculated intranasally with 100 μL
of allantoic fluid containing influenza A/mallard/Jiangxi/39/2011 (H9N2; 1 × 106 50% egg infection dose). Lung tissues were harvested on the
indicated days post-infection. The relative quantification (RQ) values for the H9N2 M gene, are expressed as fold-change. RQ values were obtained
using the 2-ΔΔCt method normalizing to the RNA expression levels of the β-actin gene. The average threshold cycle (ΔCt) values of the untreated
infected group were used for calibration
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discrepancy in the in vivo and in vitro studies is unclear.
It may be that the differences in the responses are attrib-
utable to the complex role of vitamin D in vivo, which
may affect one component of the immune system re-
sponse but not other components. This complexity






Fig. 5 Expression of pro-inflammatory and antiviral cytokines in calcitriol treated mice. Expression levels of Interleukin (IL)-6 (A), tumor necrosis factor
(TNF)-α (B), IL-2 (C), IL-4 (D) and IFN-β (E) were measured by real-time PCR in the lungs of mice treated with calcitriol. The relative quantification (RQ)
values for these genes in calcitriol-treated infected mice were calculated, and the average threshold cycle (ΔCt) values of the infected control group
were used for calibration
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function and clinical illness difficult to characterize and
may suggest differences in immune regulatory mecha-
nisms depending on the in vitro and in vivo systems
used. In developed countries, dietary supplements con-
taining vitamin D are widely used, and vitamin D sup-
plementation is now common [36]. We know that the
pathophysiology of avian influenza virus infection in
mice is significantly different from that in humans. We
hope these results will provide novel insights for add-
itional studies into the anti-inflammatory role of calci-
triol during influenza virus infection in humans.
Conclusions
Herein, we hope this study will provide some insights into
calcotriol treatment in modulating the inflammatory
response induced by influenza virus infection in humans.
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